Abstract:Epigenetic mechanisms stabilize gene expression patterns during CD8 + T cell differentiation. Although adoptive transfer of virus-specific T cells is clinically applied to reduce the risk of virus infection or reactivation in immunocompromised individuals, the DNA methylation pattern of virus-specific CD8 + T cells is largely unknown. Hence, we here performed whole-genome bisulfite sequencing of cytomegalovirus-specific human CD8 + T cells and found that they display a unique DNA methylation pattern consisting of 79 differentially methylated regions (DMRs) when compared to memory CD8 + T cells. Among the top demethylated DMRs in cytomegalovirus-specific CD8 + T cells was TBKBP1 , coding for TBK-binding protein 1 that can interact with TANK-binding kinase 1 (TBK1) and mediate pro-inflammatory responses in innate immune cells downstream of intracellular virus sensing. Since TBKBP1 has not yet been reported in T cells, we aimed to unravel its role in virus-specific CD8 + T cells. TBKBP1 demethylation in terminal effector CD8 + T cells correlated with higher TBKBP1 expression at both mRNA and protein level, independent of alternative splicing of TBKBP1 transcripts. Notably, the distinct DNA methylation patterns in CD8 + T cell subsets was stable upon long-term in vitro culture. TBKBP1 overexpression resulted in enhanced TBK1 phosphorylation upon stimulation of CD8 + T cells and significantly improved their virus neutralization capacity. Collectively, our data demonstrate that TBKBP1 modulates virus-specific CD8 + T cell responses and could be exploited as therapeutic target to improve adoptive T cell therapies. Human cytomegalovirus (CMV) is a herpesvirus that infects a significant portion of the global population. While it usually causes asymptomatic or mild infections, CMV can have severe consequences for individuals with a weakened immune system, such as stem cell or organ transplant recipients or individuals with HIV/AIDS. The immune response to CMV is characterized by expansion of virus-specific CD8 + T cells, which recognize and eliminate CMV-infected cells, thereby controlling the infection. Studies have shown that the pathogen-induced differentiation of naive to effector memory CD8 + T cells is accompanied by epigenetic changes. In order to identify the major genes involved in the functionality of CMV-specific CD8 + T cells, which are also regulated by DNA methylation, we compared the methylation profiles of CMV-specific CD8 + T cells with memory CD8 + T cells. As a result of this, we found that TBK-binding protein 1 (TBKBP1) plays a crucial role in the function of CMV-specific CD8 + T cells and enhances virus neutralization capacity upon overexpression, which has not been reported previously. This study opens the possibility of not only identifying unknown genes that contribute to the functionality of CMV-specific CD8 + T cells, but also potentially lead to improvements in adoptive T cell therapies.

Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention

Epigenetically repressing human cytomegalovirus lytic infection and reactivation from latency in THP-1 model by targeting H3K9 and H3K27 histone demethylases

The Bromodomain And Extraterminal Domain Inhibitor Bromosporine Synergistically Reactivates Latent Hiv-1 In Latently Infected Cells

Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells

HCMV modulation of cellular PI3K/AKT/mTOR signaling: New opportunities for therapeutic intervention?

Chromatin control of human cytomegalovirus infection

Specific T-cell Receptor Gene Transfer Enhances Immune Response: A Potential Therapeutic Strategy for the Control of Human Cytomegalovirus Infection in Immunocompromised Patients

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation

Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment

cGAS-STING-TBK1 Signaling Promotes Valproic Acid-Responsive Human Cytomegalovirus Immediate-Early Transcription during Infection of Incompletely Differentiated Myeloid Cells

DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8 + T cells

Viral and host network analysis of the human cytomegalovirus transcriptome in latency.

Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure

Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection

Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy

Viral microRNA regulation of Akt is necessary for reactivation of Human Cytomegalovirus from latency in CD34+ hematopoietic progenitor cells and humanized mice

Human Cytomegalovirus Primary Infection and Reactivation: Insights from Virion-Carried Molecules

Polycomb Repressive Complex 2 Silences Human Cytomegalovirus Transcription in Quiescent Infection Models

BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes

BET Bromodomain Inhibition Suppresses Human T Cell Function

The cell biology of HIV-1 latency and rebound